Display Settings:


Send to:

Choose Destination
Ann N Y Acad Sci. 2010 Dec;1213:92-105. doi: 10.1111/j.1749-6632.2010.05788.x. Epub 2010 Oct 4.

The interface between veterinary and human antibiotic use.

Author information

  • 1Department of Research and Development, Elanco Animal Health, Greenfield, Indiana 46140, USA. thomas.r.shryock73@lilly.com


The identification and early development of novel antimicrobial agents for use in veterinary medicine is subject to many of the same business and technical challenges as those found in antimicrobial agent use for human infectious disease. However, as awareness that some of the antimicrobial classes used in veterinary medicine are the same as used in human medicine, concern by multiple stakeholders has increased that this nonhuman use might be contributing to the problem of antimicrobial resistance to pathogens in humans, particularly with regard to food-borne diseases, such as salmonellosis and campylobacteriosis. Consequently, the interface between veterinary and human antibiotic use and resistance, especially with respect to human microbial food safety, has begun to redirect the industry pipeline of novel antimicrobial agents to be commercialized for use in veterinary medicine.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk